Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines.

Citation metadata

Author: Steven Joffe
Date: Jan. 19, 2021
Publisher: American Medical Association
Document Type: Viewpoint essay
Length: 48 words

Document controls

Main content

Abstract :

Insights are presented into the ethics of including a placebo arm in randomized trials of SARS-CoV-2 vaccines once authorized vaccines have become widely available. Adaptive platform trial designs can be used as an optimal approach to nimbly and ethically compare future investigational COVID-19 vaccines with proven effective ones.

Source Citation

Source Citation   

Gale Document Number: GALE|A653148096